Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Radiol. Mar 28, 2016; 8(3): 308-315
Published online Mar 28, 2016. doi: 10.4329/wjr.v8.i3.308

Table 3 Timeline for patient 3

Time (d)	Event
0	MRI
30	Angiogram with embolization of left renal AML
105	MRI
338	MRI
625	MRI
750	Angiogram with embolization of left renal AML
861	MRI
1434	MRI
2157	MRI
2158	Initiation of mTOR inhibitor
2437	MRI
2897	MRI
2897	Angiogram with embolization of left renal AML
2898	Cessation of mTOR inhibitor
3108	MRI

MRI: Magnetic resonance imaging; AML: Angiomyolipoma; mTOR: Mammalian target of rapamycin.

Citation: Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol 2016; 8(3): 308-315
URL: https://www.wjgnet.com/1949-8470/full/v8/i3/308.htm
DOI: https://dx.doi.org/10.4329/wjr.v8.i3.308

Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol 2016; 8(3): 308-315 [PMID: 27027863 DOI: 10.4329/wjr.v8.i3.308]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.